BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8672991)

  • 1. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis.
    Dave BJ; Hopwood VL; King TM; Jiang H; Spitz MR; Pathak S
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):743-9. PubMed ID: 8672991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
    Dave BJ; Risin SA; Spitz MR; Pathak S
    Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
    Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
    Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients.
    Slebos RJ; Livanos E; Yim HW; Randell SH; Parsons AM; Detterbeck FC; Rivera MP; Taylor JA
    Cancer Genet Cytogenet; 2005 Jun; 159(2):137-42. PubMed ID: 15899385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
    Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for common clonal origin of multifocal lung cancers.
    Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
    J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping.
    Wong N; Lai P; Pang E; Leung TW; Lau JW; Johnson PJ
    Hepatology; 2000 Nov; 32(5):1060-8. PubMed ID: 11050057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
    Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytogenetic studies of lung cancer].
    Fang Y
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):249-52. PubMed ID: 3248479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal abnormalities in lymphocyte cultures of individuals with colorectal polyps and of asymptomatic relatives of patients with colorectal cancer or polyps.
    Dave BJ; Hopwood VL; Hughes JI; Mellilo D; Jackson GL; Pathak S
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):587-91. PubMed ID: 8268778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients.
    Wu XF; Spitz MR; Delclos GL; Connor TH; Zhao Y; Siciliano MJ; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):527-32. PubMed ID: 8827357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [G-banded chromosome analysis of bone marrow and peripheral blood cells from small cell lung cancer (SCLC) patients].
    Su Y; Wang XQ; Wu M; Tang ZZ; Kong LH; Wang YL; Chen LM
    Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):251-4. PubMed ID: 2824149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.
    Harms C; Salama SA; Sierra-Torres CH; Cajas-Salazar N; Au WW
    Environ Mol Mutagen; 2004; 44(1):74-82. PubMed ID: 15199549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.